|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 31/436 | |
| A61K 9/127 | |||
| A61K 31/282 | |||
| A61K 31/4745 | |||
| A61K 31/475 | |||
| A61K 31/513 | |||
| A61K 31/519 | |||
| A61P 35/04 |
| (11) | Patento numeris | 3337478 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16758337.6 |
| Europos patento paraiškos padavimo data | 2016-08-19 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-06-27 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-08-12 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/047727 |
| Data | 2016-08-19 |
| (87) | Numeris | WO 2017/034957 |
| Data | 2017-03-02 |
| (30) | Numeris | Data | Šalis |
| 201562208209 P | 2015-08-21 | US | |
| 201562216736 P | 2015-09-10 | US | |
| 201562273244 P | 2015-12-30 | US | |
| 201662281473 P | 2016-01-21 | US | |
| 201662302341 P | 2016-03-02 | US | |
| 201662323245 P | 2016-04-15 | US | |
| 201662343313 P | 2016-05-31 | US |
| (72) |
BLANCHETTE, Sarah, F., US
FITZGERALD, Jonathan, Basil, US
GADDY, Daniel, F., US
HENDRIKS, Bart, S., US
KALRA, Ashish, US
LEE, Helen, US
BAYEVER, Eliel, US
|
| (73) |
Ipsen Biopharm Ltd.,
Ash Road, Wrexham Industrial Estate Wrexham LL13 9UF,
GB
|
| (54) | DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER |
| DRUG COMBINATION COMPRISING LIPOSOMAL IRINOTECAN, OXALIPLATIN, 5-FLUOROURACIL AND LEUCOVORIN FOR TREATING METASTATIC PANCREATIC CANCER |